Pioglitazone improves learning and memory in a rat model of cholinergic dysfunction induced by scopolamine, the roles of oxidative stress and neuroinflammation

Alzheimer's disease (AD) is a major neurodegenerative disorder characterized by progressive cognitive decline. Among various experimental models, scopolamine-induced amnesia is widely used to mimic memory dysfunction. Pioglitazone (PG), a thiazolidinedione derivative, has recently demonstrated...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Naunyn-Schmiedeberg's archives of pharmacology Jg. 398; H. 8; S. 10221 - 10237
Hauptverfasser: Rajabian, Arezoo, Kioumarsi Darbandi, Zahra, Aliyari, Mahdieh, Saberi, Rasul, Amirahmadi, Sabiheh, Amini, Hamideh, Salmani, Hossein, Youseflee, Pouya, Hosseini, Mahmoud
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Berlin/Heidelberg Springer Berlin Heidelberg 01.08.2025
Springer Nature B.V
Schlagworte:
Acetylcholinesterase
Acetylcholinesterase - metabolism
Alzheimer's disease
Amnesia
Animal cognition
Animal models
Animals
Avoidance Learning - drug effects
Behavior, Animal - drug effects
Biomedical and Life Sciences
Biomedicine
Brain
Cognitive ability
Cognitive Dysfunction - chemically induced
Cognitive Dysfunction - drug therapy
Dementia
Disease Models, Animal
Gene expression
Hippocampus
Hippocampus - drug effects
Hippocampus - metabolism
IL-1β
Inflammation
Interleukin 6
Laboratory animals
Learning
Male
Maze Learning - drug effects
Memory
Memory - drug effects
Memory Disorders - chemically induced
Memory Disorders - drug therapy
Neurodegeneration
Neurodegenerative diseases
Neuroinflammatory Diseases - drug therapy
Neuroinflammatory Diseases - metabolism
Neuroprotection
Neuroprotective Agents - pharmacology
Neuroprotective Agents - therapeutic use
Neurosciences
Oxidative stress
Oxidative Stress - drug effects
Pharmacology/Toxicology
Pioglitazone
Pioglitazone - pharmacology
Pioglitazone - therapeutic use
Rats
Rats, Wistar
Scopolamine
Superoxide dismutase
Tumor necrosis factor-TNF
Tumor necrosis factor-α
Oxidative stress
Neuroinflammation
Scopolamine
Pioglitazone
Cognitive impairment
ISSN:0028-1298, 1432-1912, 1432-1912
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Alzheimer's disease (AD) is a major neurodegenerative disorder characterized by progressive cognitive decline. Among various experimental models, scopolamine-induced amnesia is widely used to mimic memory dysfunction. Pioglitazone (PG), a thiazolidinedione derivative, has recently demonstrated neuroprotective potential in neurodegenerative conditions. This study aimed to evaluate the potential benefits of PG in mitigating scopolamine-induced cholinergic dysfunction and the associated memory and learning deficits in male Wistar rats. Fifty male Wistar rats were randomly assigned to five groups: (1) Control, (2) Scopolamine, and (3–5) three treatment groups receiving daily injections of PG at doses of 20, 40, or 60 mg/kg for three weeks in addition to scopolamine administration. Cognitive impairment was induced using scopolamine in all groups except the control. Cognitive function was assessed using the Morris water maze (MWM) and passive avoidance (PA) tests. Biochemical analyses were conducted to measure malondialdehyde (MDA), superoxide dismutase (SOD), total thiol levels, and acetylcholinesterase (AChE) activity in the cortex and hippocampus. Additionally, mRNA expression levels of inflammatory markers (TNF-α, IL-1β, IL-6) were evaluated in the hippocampus. Scopolamine induced cognitive impairment, increased MDA levels and AChE activity, decreased SOD activity and thiol levels, and elevated mRNA expression of inflammatory cytokines. PG significantly reversed these effects by enhancing performance in the MWM and PA tests, reducing MDA levels and AChE activity, and increasing SOD activity and total thiol concentration. Additionally, PG downregulated TNF-α, IL-1β, and IL-6 expression in brain tissue. The present behavioral and neurochemical findings suggest that PG ameliorates scopolamine-induced memory impairment by reducing oxidative stress and neuroinflammation while enhancing cholinergic function.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0028-1298
1432-1912
1432-1912
DOI:10.1007/s00210-025-03895-5